We are live on ! Find out more
ACER

Acer Therapeutics Inc

Delisted

ACER was delisted on the 8th of November, 2023.

15 hedge funds and large institutions have $1.19M invested in Acer Therapeutics Inc in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

25% more funds holding

Funds holding: 1215 (+3)

8% more capital invested

Capital invested by funds: $1.1M → $1.19M (+$85K)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ACER Hedge Fund Activity: Q4 2015 in Review

15 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2015, worth a combined $1.19M — up 7.7% from $1.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ACER positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $315K. The largest seller was A.R.T. Advisors, cutting an estimated $14K.

  • 15 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2015, up from 12 in Q3 2015.
  • Funds reported $1.19M of Acer Therapeutics Inc stock for Q4 2015, up 7.7% quarter-over-quarter.
  • 6 funds opened new Acer Therapeutics Inc positions in Q4 2015 and 3 closed out, a net change of +3 holders.
  • The largest Acer Therapeutics Inc buyer in Q4 2015 was Sabby Management, an estimated $315K added.
  • The largest Acer Therapeutics Inc seller in Q4 2015 was A.R.T. Advisors, an estimated $14K sold.

Based on aggregated 13F filings for Q4 2015.